Drug intelligence / Profile preview

Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate

Development stage
Unknown
Modality
Small Molecules
01

Overview

Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate is a synthetic nucleoside analog with the chemical formula C11H18AsN5O12P2. It contains an arsono group, distinguishing it from similar methyleneadenosine diphosphate compounds. While it has been assigned a DrugBank ID (DB02937) and is classified as an experimental drug, detailed information regarding its specific mechanism of action, primary indications, or therapeutic applications is not readily available in public databases.

Other names
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-(arsonomethyl)phosphinic acid{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(arsonomethyl)(hydroxy)phosphoryl]oxy})phosphinic acid(((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)((((arsonomethyl)(hydroxy)phosphoryl)oxy))phosphinic acidgamma-methyleneadenosine-5'-diphosphategamma-arsono-beta5'-O-[(S)-{[(R)-(arsonomethyl)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]adenosine
02

Targets

NadE (Brain-expressed X-linked protein 3)GCK (Glucokinase)

Beyond the preview

Go deeper on Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call